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INVESTIGATION

Large Deletions at the SHOX Locus in the
Pseudoautosomal Region Are Associated with
Skeletal Atavism in Shetland Ponies
Nima Rafati,*,1 Lisa S. Andersson,†,1 Soﬁa Mikko,†,1 Chungang Feng,* Terje Raudsepp,‡
Jessica Pettersson,* Jan Janecka,‡ Ove Wattle,§ Adam Ameur,** Gunilla Thyreen,† John Eberth,††
John Huddleston,‡‡,§§ Maika Malig,§§ Ernest Bailey,†† Evan E. Eichler,§§ Göran Dalin,***
Bhanu Chowdary,††† Leif Andersson,*,†,‡ Gabriella Lindgren,† and Carl-Johan Rubin*,2
*Department of Medical Biochemistry and Microbiology, and **Department of Immunology, Genetics and Pathology,
Science for Life Laboratory, Uppsala University, Sweden 751 23, †Department of Animal Breeding and Genetics,
§Department of Clinical Sciences, and ***Department of Anatomy, Physiology and Biochemistry, Swedish University of
Agricultural Sciences, Uppsala, Sweden 750 07, ‡Department of Veterinary Integrative Biosciences, Texas A&M
University, College Station, Texas 77845, ††Gluck Equine Research Center, Department of Veterinary Science, University
of Kentucky, Lexington, Kentucky 40546, ‡‡Department of Genome Sciences, University of Washington School of
Medicine, Seattle, Washington 98105, §§Howard Hughes Medical Institute, University of Washington, Seattle,
Washington 98195, and †††New Research Complex, Qatar University, Doha, Qatar 2713

ABSTRACT Skeletal atavism in Shetland ponies is a heritable disorder characterized by abnormal growth of the
ulna and ﬁbula that extend the carpal and tarsal joints, respectively. This causes abnormal skeletal structure and
impaired movements, and affected foals are usually killed. In order to identify the causal mutation we subjected six
conﬁrmed Swedish cases and a DNA pool consisting of 21 control individuals to whole genome resequencing. We
screened for polymorphisms where the cases and the control pool were ﬁxed for opposite alleles and observed this
signature for only 25 SNPs, most of which were scattered on genome assembly unassigned scaffolds. Read depth
analysis at these loci revealed homozygosity or compound heterozygosity for two partially overlapping large
deletions in the pseudoautosomal region (PAR) of chromosome X/Y in cases but not in the control pool. One of
these deletions removes the entire coding region of the SHOX gene and both deletions remove parts of the CRLF2
gene located downstream of SHOX. The horse reference assembly of the PAR is highly fragmented, and in order to
characterize this region we sequenced bacterial artiﬁcial chromosome (BAC) clones by single-molecule real-time
(SMRT) sequencing technology. This considerably improved the assembly and enabled size estimations of the two
deletions to 1602180 kb and 60280 kb, respectively. Complete association between the presence of these
deletions and disease status was veriﬁed in eight other affected horses. The result of the present study is consistent
with previous studies in humans showing crucial importance of SHOX for normal skeletal development.

Hereditary skeletal anomalies have been described in certain breeds of
horse, including lateral patellar (sub)luxation in Shetland ponies
(Hermans et al. 1987) and dwarﬁsm with disproportional back and
short limbs in Friesian horses (Back et al. 2008; Orr et al. 2010), but
in neither of these cases has a causal variant been reported. It has
however been suggested that mutations in Aggrecan (ACAN) are associated with chondrodysplasia-like dwarﬁsm in miniature horses
(Eberth et al. 2009).
Shetland ponies born with abnormally developed ulna and ﬁbula
have been described since the 1950s (reviewed in Hermans 1970). In
horses, “full length” development of ﬁbula and ulna to include the
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carpal and tarsal joint, respectively, results in splayed legs and movement difﬁculties (Figure 1). Shorter than normal humerus, femur, and
tibia, in relation to the third metatarsal bone, are also observed and
affected individuals usually have to be killed at an early age (Tyson et al.
2004). Fossil records show that approximately 15 million yr ago, in the
ancestors of modern equids, ulna and ﬁbula were reduced in size and
were fused to the radius and tibia, respectively (reviewed in Hall 1995;
Tyson et al. 2004). The reappearance of properties previously seen at an
earlier evolutionary stage of a species is referred to as an atavism (Hall
1995) and the disease in Shetland ponies has therefore been referred to
as skeletal atavism (SA). Other examples of atavisms include hind limbs
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in whales (Tomic and Meyer-Rochow 2011), hypertrichosis (excess of
hair) in human (DeStefano et al. 2013), and polydactyly in horses
(Carstanjen et al. 2007).
The ﬁrst affected Shetland ponies were reported in 1958 in the UK
where lameness and limb deformities were observed in some pedigrees
(Tyson et al. 2004), and previously published data have been consistent
with an autosomal recessive inheritance (Hermans 1970; Hermans
et al. 1987; Tyson et al. 2004). Due to SA occurring in the UK, Netherlands, and Sweden since the 1960s, it is important to reveal the genetic
basis of the disease and to develop a diagnostic test that can be used to
avoid mating disease allele carriers. In a ﬁrst attempt to unravel the
genetic basis of this disorder we performed a genome-wide association
study (GWAS) of 72 individuals (36 controls, 22 carriers, and 14 cases)
using the Illumina EquineSNP50 BeadChip. This analysis did not reveal
any association between genetic markers and disease status. Instead, we
performed whole genome resequencing of six SA cases and a pool of
control horses and use this data to show that skeletal atavism is associated with two, partially overlapping, large deletions on sequence scaffolds not assigned to any chromosome in the EquCab2.0 genome
assembly. The genotyping array used for the GWAS had no markers
near this associated region. One of the identiﬁed deletions removes the
entire coding region of the short stature homeobox (SHOX) gene and
both deletions remove parts of the cytokine receptor-like factor 2
(CRLF2) gene located downstream of SHOX.
MATERIALS AND METHODS
Animals
The study was approved by the Ethics Committee for Animal Experiments in Uppsala, Sweden (application number C121/14).
Swedish samples
Samples subjected to whole genome sequencing: Individuals selected
for control pool inclusion (n = 21) were stallions having no conﬁrmed
atavistic offspring despite having sired at least 50 registered offspring.
Six SA cases, two of which had been conﬁrmed by X-ray, were sequenced individually.
Samples selected for validation: Obligate carriers (n = 17) were selected based on conﬁrmed SA affected offspring (of which four did not
have an offspring among tested cases), while potential carriers (n = 15)
were selected because they were close relatives of known or unveriﬁed
carriers (n = 10) or parents of unveriﬁed cases (n = 5). In addition to the
SA cases subjected to whole genome resequencing, we genotyped four
other Swedish cases, three of which had been conﬁrmed by X-ray. The
random set consisted of 94 Shetland ponies randomly selected from the
biobank at the Animal Genetics Laboratory, SLU, Sweden. The horses
were born between 1968 and 2000 (average birth year 1991, 70% of the
Copyright © 2016 Rafati et al.
doi: 10.1534/g3.116.029645
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individuals were born in the 90s) and consisted of 72 males and 22 females. For the height study we also used all individuals with available
height and sex data (except cases). In addition, we could infer the genotype of seven horses and genotyped eight extra horses collected from
the biobank because both DNA and height data were available.
American samples: In total, 18 US horses were genotyped. Four cases
were identiﬁed by horse owners and samples submitted in connection
with investigations of another form of congentital dwarﬁsm (Eberth
et al. 2009). Photographs were used to identify atavistic samples, and to
conﬁrm phenotypic characteristics. Only one carrier, conﬁrmed by
producing atavistic offspring, was included. Controls were individuals
with no conﬁrmed cases of producing atavistic offspring.
BAC clone selection, sequencing, and assembly
BAC libraries were generated from a half-brother (“Bravo”) of the
female Thoroughbred horse (“Twilight”) used for the EquCab2.0 genome assembly. This BAC library (CHORI-241) was developed by
BACPAC Resource center (BPRC) at Children’s Hospital Oakland Research Institute (CHORI), Oakland, CA. We ﬁrst aligned the BAC end
sequences to the deleted regions and selected clones overlapping parts
of the deleted regions. In total we sequenced nine BAC clones: 194E12,
288L23, 50P17, 52P20, 159K1, 442L16, 291B18, 712C2, and 419P11
(Supplemental Material, Table S3).
After assembly, for quality control, we checked the coverage of
assembled contigs and screened for contaminations by aligning the
contigs on UniVec (Version 2012-09-24). After aligning the assemblies against EquCab2.0, we generated consensus sequences based on
overlapping similarity between BAC clone assemblies and coordinates on EquCab2.0. We compiled three contigs based on assemblies
of ﬁve out of the nine BACs covering regions surrounding SHOX and
used these contigs for downstream analysis (Table S4 and Figure
4A).
We aligned three BAC-derived consensus contigs to human chrX
(GRCh37) by MUMmer 3.0 (Kurtz et al. 2004) and then identiﬁed
regions showing sequence conservation.
SMRT BAC clone sequencing and assembly (Washington
School of Medicine)
DNA was isolated from CHORI-241 BAC clones. PacBio SMRTbell
libraries were prepared (Travers et al. 2010) and sequenced on a RSII
with P4-C2 chemistry (one SMRT cell/BAC sample with one 120 min
movie). Inserts were assembled using hierarchical genome-assembly
process (HGAP) and Quiver as previously described (Chin et al.
2013; Huddleston et al. 2014).
SMRT BAC clone sequencing and assembly (SciLife
Lab, Uppsala)
SMRTbell libraries were produced using the Paciﬁc Biosciences 1.0
template preparation kit according to the manufacturer’s instructions.
SMRTbell were constructed and sequenced following the recommended Paciﬁc Biosciences 2-kb template preparation protocol. In
brief, the BACs (5002700 ng) were sheared into 2-kb fragments by
the Covaris S2 system using clear miniTUBEs following the manufacturer’s recommendations. The sheared DNA then underwent endrepair and adaptor ligation processes to generate SMRTbell libraries
for circular consensus sequencing. Libraries were then subjected to
exonuclease treatment and Ampure bead wash procedures for cleanup.
SMRTbell libraries were quantiﬁed using the Qubit assay and library
size was conﬁrmed using the Bioanalyzer 12000 kit. Following

Figure 1 Limbs of a 16-wk-old Shetland pony with skeletal atavism. (A)
View from the front when standing
square, (B) caudal view when standing,
and (C) caudal view at walk. Complete
ﬁbulas and ulnas cause instability in
the tarsocrural and antebrachiocarpal
joints, respectively; angular limb deformities become more severe at walk.
(D–G) Computed tomography scans of
the 16-wk-old Shetland pony’s gaskin
and forearm. Dorsal views of tibia and
complete ﬁbula, right (D) and left (E)
hind limbs. (F) Dorsal and (G) lateral
views of left front limb radius and complete ulna. (H) Computed tomography
scans showing dorsal and (I) lateral
views of normally developed radius
and ulna, with the ulna about to be
fused to the radius, of a 16-wk-old
nonatavistic Swedish Warmblood foal.

SMRTbell construction, v2 primers and P4 polymerase were annealed
and the enzyme bound complexes attached to magnetic beads for
loading. Each SMRTbell library was loaded on to one SMRT cell
and sequenced on the PacBio RSII instrument using C2 chemistry
and a 240 min movie time. The resulting reads were de novo assembled into contigs using the HGAP algorithm (Chin et al. 2013) available in the SMRT analysis portal.

Resequencing, alignment, and SNP calling
Using standard protocols, we isolated DNA from blood of six affected
horses and 21 male Swedish Shetland ponies with no history of having
sired affected foals, and combined equimolar quantities of DNA from
these in a DNA pool. One paired-end Illumina sequencing library was
generated for each case and two libraries were constructed for the control
pool by applying a standard protocol at the SNP&Seq Illumina platform
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at the Science for Life laboratory at Uppsala University, Sweden. These
libraries were sequenced as paired-end reads (2 · 100 bp) by Illumina
Hiseq2000 (Table S1). We mapped reads of all samples on the horse
draft genome assembly (EquCab2.0) using the Burrows-Wheeler alignment (BWA) software (Li and Durbin 2010). After marking duplicated
reads by Picard (v1.92 http://picard.sourceforge.net) we realigned
reads around InDels and called SNPs by GATK UniﬁedGenotyper
(McKenna et al. 2010). In order to screen for sequencing depth of
coverage we ﬁrst extracted per-position genome-wide depths of each
sample by the GATK command DepthOfCoverage and then calculated
normalized depths for 1-kb windows along the genome using custom
python scripts available at github. We used allele-speciﬁc read counts at
SNPs and depth of coverage data for our ﬁrst screen where we identiﬁed
regions where cases consistently deviated from the control pool with
regard to allele frequencies at SNPs or normalized depth.
In order to identify new variation based on new BAC clone
assemblies we ﬁrst combined BAC-derived consensus sequences
with EquCab2.0 excluding overlapping sequences with more than
50% similarities to BAC-derived consensus sequences. We followed
the same pipeline as for alignments on EquCab2.0 but we recalibrated our alignments with available horse SNP from Ensembl77
before calling SNPs and InDels. After ﬁltering the data based on
GATK best practice ﬁlters we identiﬁed 9,844,628 SNPs and
1,111,009 InDels.
GenScan on SMRT sequencing contigs
We scanned the BAC-derived consensus contigs for possible protein
coding genes using GenScan (Burge and Karlin 1997). Then we aligned
the predicted peptide sequences to the nr database by BLASTp
(Altschul et al. 1990) and visualized the corresponding regions on
human chrX. One of the identiﬁed protein coding genes was CRLF2,
which aligned on human chrX and part of this prediction was located
inside of Del-2. In order to characterize the coding sequence more
precisely we used data from 24 RNA-seq runs (SRA number:
SRP012972) generated from blood and muscle of six Thoroughbred
horses before and after exercise (Kim et al. 2013). After trimming the
reads by trimmomatic (Bolger et al. 2014), we aligned the RNA-seq
reads to the alternative EquCab2.0 genome by GSNAP (Wu and Nacu
2010) and then assembled the transcripts by cufﬂinks (version 2.2.1)
(Trapnell et al. 2010). The assembled transcripts on BAC-C3 were
translated to protein sequence by Emboss Transeq (Goujon et al.
2010) and resulting protein sequences were then aligned to UniProt
database (UniProtConsortium 2015) (downloaded on 18 October
2015) by BLASTp.
Genotyping
We genotyped a group of Swedish and American samples including
cases, obligate/potential carriers, and controls by using TaqMan assays
designed based on Del-1 and Del-2 sequences from EquCab2.0. As
reference assay we used RNAseP (Table S6). Reactions contained 20 ng
DNA that was not digested with any restriction enzyme but otherwise
analyzed as described below, using the ddPCR platform.
We also genotyped a random set of Shetland ponies (94 individuals)
and individuals with known phenotypes by using TaqMan assays
designed from BAC-derived consensus contigs on a droplet ddPCR
instrument. In this experiment we used an assay targeting myostatin
(MSTN) as a reference, three assays targeting Del-1 sequences, and
three assays targeting Del-2 sequences (Table S6). The sequences of
Del-1 and Del-2 are highly polymorphic, which may affect assay performance. Thus, we consulted Illumina read alignments to place primers and probes in nonpolymorphic regions and also designed three
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assays for each deletion to use alternative assays in case genotyping
results appeared unreliable.
The ddPCR experiments were performed using the Bio-Rad QX100
ddPCR platform. We ﬁrst digested the DNA with FastDigest Eco47I
restriction enzyme (Thermo Scientiﬁc). The ﬁnal reaction contained
33 ng digested DNA, 900 nM of each primer, and 250 nM of each probe.
Twenty microliters of the reaction was loaded into a droplet generator
cartridge. Droplets were generated following the manufacturer’s suggested protocol. Cycling conditions were 95 for 10 min, followed by
40 cycles of 94 for 30 sec and 60 for 1 min, and a ﬁnal 10 min at 98.
The PCR plate was transferred to QX100 droplet reader for reading and
the data were analyzed using the software QuantaSoft. For ambiguous
events, we used the ellipse, rectangle, and Lasso threshold in order to
adjust the classiﬁcation of clusters. To classify genotypes of individuals
we considered a range for the measured copy numbers as follows: two
copies (1.7–2.3), one copy (0.7–1.3), and for null copy we did not ﬁnd
any outliers to adjust the range.
We performed ANOVAs to test the association between height,
deletion genotypes and sex by using the following models:
Height ¼ genotype class þ sex

(1)

where genotype_class consists of Del_carriers (Del-1/wild type (WT)
and Del-2/WT together) and WT/WT.
Height ¼ genotype þ sex

(2)

where genotype consists of Del-1/WT, Del-2/WT, and WT/WT.
Data availability
All the sequencing data are available from National Center for
Biotechnology Information (NCBI) under the accession number
PRJNA303134. The python script used to calculate normalized depth of
coverage is available for download at https://github.com/cjrubinlab/
python_scripts.git (CalcCovGATKDepthFiles_1kb.py).
RESULTS
Genome resequencing reveals complete association
between disease status and the presence of two
deletions in the pseudoautosomal region (PAR)
Our ﬁrst screen for causal alleles involved GWAS using the EquineSNP50 BeadChip, which did not reveal any association between
genetic markers and disease status. As an alternative we selected six
affected individuals and a pool of control individuals for whole genome
resequencing. For the control pool, we selected males without known
history of siring affected foals. We generated 7X sequence coverage for
each case and 56X coverage for the control pool (Table S1). More than
94% of the reads were aligned to the equine reference genome and we
scanned these alignments to identify SNPs and small Insertion/Deletions (InDels). Since the mode of inheritance of the disease was
expected to be autosomal recessive we identiﬁed all SNPs with an allele
frequency difference of 1.0 between cases and controls and where the
control pool only had reference alleles. Two SNPs on anchored chromosomes (chr1) and 23 SNPs on unassigned scaffolds fulﬁlled the
sought pattern, but only for cases 2, 3, and 4, with the other three
samples having no reads spanning these SNP positions. Seventeen
out of the 23 SNPs on unassigned scaffolds were located on contigs
belonging to assembly scaffold chrUn0036, and spanned between
chrUn:26,645,953-26,779,752 (EquCab2.0 UCSC genome browser coordinates), a region containing the SHOX gene. Careful examination of
genetic variants and sequence read depth in these contigs revealed a

Figure 2 SNP genotypes and depth pattern on EquCab2.0 unassigned scaffold chrUn0036. (A) SNP genotypes of SA cases. (B) Normalized copy
numbers of SA cases in relation to the control pool and Z-score transformation of control pool depth in relation to the average depth over the
entire genome. The region shown is chrUn: 26.6226.9 Mb in UCSC genome browser concatenation of unassigned scaffolds.

consistent difference for several unassigned scaffolds where three of the
SA cases (2, 3, and 4) were homozygous for variant alleles while the
other three SA cases were entirely lacking sequence reads. In contrast,

the control pool had normal depth of coverage (Figure 2, A and B). We
further concluded from read depth analyses that three SA cases (1, 5,
and 6) were homozygous for a large deletion over this region. The other
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Figure 3 The organization of the PAR in eutherian
species. The gene map of HSAXp (left) serves as a
reference (see Raudsepp and Chowdhary 2016).

three SA cases (2–4) showed approximately 50% reduction in read
depth over most of this deletion but were also deleted for a segment
overlapping the ﬁrst deletion. These two deletions were scattered on
chrUn (scaffolds that were not assigned to chromosomes in the EquCab2.0 genome assembly) removing 160 kb of EquCab2.0 sequence
in cases (Table S2). We named the larger deletion Del-1 and the smaller
Del-2. We observed a consistent depth difference on unassigned scaffold chrUn0036, containing 19 contigs (EquCab2.0 UCSC genome
browser coordinates chrUn: 26,650,752–26,745,752) (Figure 2B). The
heterogeneity of genotypes of cases 2–4 in this region in Figure 2A is
due to less stringent ﬁlters applied to call SNPs in hemizygous cases.
The chrUn0036 scaffold did not contain any complete equine
Ensembl protein annotation or RefSeq annotation, but we observed
reliable alignments to SHOX RefSeq gene models from other species
as visualized by Canis familiaris SHOX alignment. SHOX is a homeobox transcription factor involved in growth and expressed during development (Benito-Sanz et al. 2012). SHOX is located in the
PAR of most eutherian mammals (Raudsepp et al. 2012) (Figure 3)
but is absent from rodent genomes (Benito-Sanz et al. 2012). We
concluded that Del-1 deletes the entire SHOX gene and that Del-2 is
located proximal of SHOX in a region possibly containing SHOX
regulatory elements.
A long-read assembly of the SHOX regions
The EquCab2.0 assembly is highly fragmented over the PAR and
therefore, identifying the Del-1 and Del-2 breakpoints from short
read alignments proved futile. We attempted de novo assemblies
using short reads from SA cases, which resulted in very fragmented
assemblies. As an alternate strategy, we applied single-molecule realtime (SMRT) sequencing technology (PacBio) to sequence largeinsert BAC clones generated from the equine CHORI-241 BAC
library (http://bacpac.chori.org). We selected nine clones whose
end sequence alignments formed a tiling path along the PAR on
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both sides of the SHOX coding sequence (Table 1, Table S3, and
Figure S1). After quality control, error-correction, and assembly we
merged contigs based on overlapping similarities in relation to EquCab2.0. We based downstream analyses on the sequence assembly of
three BAC-derived consensus contigs generated from ﬁve sequenced BAC clones (Table S4 and Figure 4A).
We generated an alternative genome assembly by merging these
BAC-derived consensus sequences together with the EquCab2.0, excluding parts of EquCab2.0 represented also in the BAC-derived consensus sequences.
Detection of deletion breakpoints
We next aligned the short reads from all cases and the control pool to this
alternative genome assembly, determined copy numbers (Figure 4B)
and called SNPs using stringent ﬁltering. The Del-1 depth pattern, i.e.,
complete lack of aligned reads for cases 1, 5, and 6, an approximate
50% reduction in depth for cases 2, 3, and 4, and normal depth in the
control pool, was observed for 97 kb on BAC-C1 (BAC-C1
133,0002230,000 bp). A presumed breakpoint (BP1) (Figure 4B)
ﬂanked by a stretch of a TGGA repeat was observed in this contig. In
the other two BAC-derived sequences (BAC-C2 and BAC-C3) we
identiﬁed regions showing the Del-2 pattern (i.e., all the cases lacked
depth while the control pool had normal depth). Interestingly, within
the Del-2 region of BAC-C3 we identiﬁed a coding sequence showing
partial similarity to human CRLF2 (Figure 4B). This gene is located
downstream of SHOX in human and horse (Figure 3) (Raudsepp and
Chowdhary 2008; Raudsepp et al. 2012). We improved the annotation of this gene by using previously published RNA-seq data from
Thoroughbred horses (Kim et al. 2013).
Based on these observations we estimated Del-2 to encompass
60280 kb of the genome, with the size uncertainty being a result of
an evident mis-assembly in BAC-C2. We observed an enrichment of
soft-clipped reads in the control pool immediately adjacent to BP2

n Table 1 BAC clone assemblies generated from SMRT sequencing data (see Table S3 for detailed information)
BAC Clones
194E12c
288L23c
50P17c
52P20
159K1c
442L16
291B18
712C2c
419P11c

Assembly Size (bp)

#Contigs

GCa%

Assembly Fractionb %

155,628
186,195
147,467
66,939
47,668
58,892
107,104
140,175
73,186

1
7
1
2
4
1
3
1
1

59.7
58.3
58.6
54.4
53.5
55.9
54.7
55.8
57.9

72
NA
70
34
NA
31
60
NA
37

a
G/C nucleotide content of assembly.
b
Fraction of BAC assembled based on anticipated size from BAC end sequence alignment. NA = not applicable because the anticipated size of the BAC is not known.
c

These BACs were included in the previously published PAR BAC contig map (Raudsepp and Chowdhary 2008).

(BAC-C2: 28,000230,000 bp), which we were unable to amplify over
by PCR. In addition, there was not a single read pair bridging over this
problematic region in the control pool.
As was the case for BP1 of Del-1 on BAC-C1, the sequence
ﬂanking BP3 on BAC-C3 featured a stretch of TGGA repeats longer
than 1 kb. Because of these repeats, we could not characterize the
breakpoints using mapping data of the paired-end Illumina reads
from the sequenced SA cases. Using DNA from SA cases we attempted PCR-based chromosome walking to extend this region into the
downstream sequence of the deletion but these efforts proved futile,
possibly due to complexity of this region, such as high repeat and G/C
nucleotide content.
Diagnostic tests for Del-1 and Del-2
In order to validate ﬁndings from the sequencing efforts and to estimate
Del-1 and Del-2 allele frequencies we designed TaqMan copy number
assays for genotyping by droplet digital PCR (ddPCR). We genotyped
two sets of samples: (i) cases, obligate carriers, potential carriers being
close relatives to known carriers or having had unconﬁrmed affected
foals, and control individuals without history of having sired any affected
foals (in total 63 Swedish Shetland ponies and 18 American miniature
horses); and (ii) a random set of Swedish Shetland ponies. Table S5 and
Figure 5A show the results of genotyping. All SA cases but no controls
nor carriers were homozygous Del-1, homozygous Del-2, or hemizygous Del-1/Del-2. Most control individuals formed a separate cluster
showing two copies for each targeted locus while obligate carriers were
genotyped as either Del-1/WT or Del-2/WT. Ten individuals in the
potential carrier group clustered with obligate carriers as Del-1/WT
or Del-2/WT while ﬁve of them were WT/WT. In the random set of
94 Swedish Shetland ponies, 11.7% of horses were identiﬁed as Del-1 or
Del-2 carriers. In this randomly selected set of samples we observed
carriers (n = 11) and WT allele homozygotes (n = 83) but no Del-1 or
Del-2 homozygotes nor compound Del-1/Del-2 heterozygotes (Figure
5B and Table S5). Based on genotypes observed in the random set of
samples we estimated the allele frequencies of Del-1 and Del-2 to be
4.79% and 1.06%, respectively, in the Swedish Shetland pony population at the time of sampling, between 1968 and 2000 (70% of the
individuals were born in the 1990s).
In the current set of samples (n(total) = 130), we examined the
association of height at withers with deletion genotypes. No signiﬁcant
difference in height could be revealed between carriers [Del-1/WT (n =
32) and Del-2/WT (n = 8)] and WT/WT (n = 90) when considering sex
as covariate (ANOVA P = 0.25; Figure 5C). Furthermore, no signiﬁcant
association with height was found for the three genotypes (Del-1/WT,
Del-2/WT, and WT/WT) and sex (P = 0.31).

DISCUSSION
GWAS based on the EquineSNP50 BeadChip did not reveal any
association and we conclude that this was because only anchored
chromosomes were used for selection of SNPs in the early BeadChip
versions. Here we performed whole genome resequencing of six cases
and a DNA pool of control individuals and revealed two causal variants;
two large deletions (160 and 80 kb in size) of sequences only partially represented in the EquCab2.0 assembly as unanchored scaffolds,
occurring in conjunction with and overlapping the SHOX gene, respectively. Three of the sequenced cases were homozygous for Del-1,
which spans the entire SHOX gene, while the other three were heterozygous Del-1/Del-2, but due to partial overlap of the deletions all cases
shared 60280 kb of deleted sequence downstream of SHOX including
the deletion of another gene (CRLF2). In the BAC assemblies we did not
observe any sequence unique to Del-2, which appears to completely
correspond to the distal part of Del-1. By sequencing and assembling
BAC clones we could order contigs and annotate the CRLF2 gene more
accurately than in EquCab2.0, which was quite fragmented in this
region.
SHOX expression is crucial during development, as SHOX is involved in cell cycle regulation and acts as a transcriptional activator in
osteogenic cells (Rao et al. 2001). Regulation of SHOX expression
is complex at the transcriptional and translational levels (Blaschke
and Rappold 2006), impairment of regulatory elements can affect its
expression, and missense and nonsense mutations have also been reported to alter the structure and consequently the activity of the protein
(Ross et al. 2001; Jorge et al. 2007; Chen et al. 2009; Benito-Sanz et al.
2012). Deﬁciency and haploinsufﬁciency of SHOX have been associated
with skeletal defects involving short stature and limb deformities in
humans (Jorge et al. 2007; Chen et al. 2009; Raudsepp et al. 2012).
Benito-Sanz et al. (2012) identiﬁed a 47-kb deletion downstream of
SHOX as the disease-causing allele in Léri-Weill dyschondrosteosis
(LWD) and idiopathic short stature (ISS) patients. Chen et al. (2009)
also reported that microdeletions located 250 kb downstream of this
gene can lead to short stature.
In addition to the homozygous/hemizygous deletion of the coding
sequence of SHOX, all the SA cases had homozygous deletions over the
predicted coding sequence of CRLF2. The CRLF2 protein is a type
1 cytokine receptor involved in hematopoietic cell development and
in the JAK-STAT pathway, active in bone metabolism and development (Al-Shami et al. 2004; Li 2013; Hanada et al. 2014). Poggi et al.
(2015) reported large deletions in PAR spanning SHOX and CRLF2 in
some of the LWD patients, but the common feature among LWD cases
is deletions spanning SHOX. Thus, although we cannot exclude that the
deletion of CRLF2 is involved in the phenotypic expression of SA, we
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Figure 4 Depth of coverage for cases and the control pool along SMRT sequencing-derived consensus sequences. (A) BAC assembly contigs used to
generate consensus sequence BAC-C1. BAC 291B18 assembled into three contigs. (B) Normalized copy numbers observed in 1-kb windows along BACcontigs BAC-C2 and BAC-C3 as well as BAC-derived consensus contig BAC-C1. Syntenic similarity to human is visualized as red lines combining each
contig/BAC-derived consensus sequence with coordinates on the PAR of human ChrX. BAC-C2 did not have any syntenic similarity to human Chr. X.
BP1-3 indicate predicted deletion breakpoints; long stretches of TGGA repeats occurred at both BP1 and BP3. Predicted protein coding genes with
similarity to human genes are visualized using red boxes. The CRLF2 gene model was improved using RNA-seq data (Kim et al. 2013).
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Figure 5 Diagnostic test for Del-1 and Del2. (A) TaqMan genomic copy number assay
results from analysis of cases, carriers, and
controls from Sweden (SW) and the USA
(US). Potential carriers are parents to unveriﬁed cases or close relatives to veriﬁed
carriers and obligate carriers are known to
have produced conﬁrmed atavistic offspring. Numbers of individuals genotyped
in each group are presented in parentheses
to the right. (B) TaqMan genomic copy
number assay results from analysis of 94 individuals randomly selected from the Swedish Shetland pony population together with
observed allele frequencies. (C) Height at
withers distribution subdivided by sex and
genotype. For this analysis we included all
genotyped individuals with height and sex
data available (except cases) and seven
carriers that had not been genotyped but
whose genotype could be inferred by
pedigree information.

argue that the similarity to human phenotypes caused by SHOX deﬁciency support the interpretation that SA is manifested by a reduction
of SHOX expression. The deletion of CRLF2 may affect other hitherto
unexplored phenotypes in affected horses and possibly also in carriers.

SHOX and CRLF2 are both located in the PAR, which like autosomes experiences recombination in both sexes, and is not subjected to
X-inactivation in females (Brown and Greally 2003). This region has
the highest recombination rate in the human genome and a high
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incidence of structural changes (Blaschke and Rappold 2006). The high
G/C nucleotide content and repeat content of the PAR can explain the
difﬁculties in sequencing and assembling this part of the genome,
especially using short read sequencing data. Even in human, because
of these complexities, 600 kb of PAR has still not been assembled
(Blaschke and Rappold 2006). However, these complex regions can be
better resolved by utilizing long-read sequencing data (Huddleston
et al. 2014). By using SMRT sequencing we were able to considerably
improve the assembly of the SHOX locus in horse. Despite this improvement, it still proved challenging to resolve and precisely identify the
deletion breakpoints. Our results show that the breakpoints are enriched
by long stretches of microsatellites (TGGA)n and this type of repeat can
cause chromosomal rearrangements (Bena et al. 2010). Expanded pairs
of homologous repeats, such as (TGG)n, form strong secondary structures inhibiting DNA synthesis as length of the repeat increases (Usdin
1998). For instance, a 1.11-Mb deletion on human 14q32 has been shown
to be mediated by such a repeat (Bena et al. 2010).
In addition, these repeats are unstable, leading to replication slippage
or increased chance of recombination by which new structural changes
can be introduced (Fry and Usdin 2006). Repeat instability is a complex
feature of the genome and is expected to be inﬂuenced by many factors
and pathways. Our efforts to bridge across the breakpoints failed, likely
due to complex structure of this region inhibiting DNA polymerase
activity. The best approach at hand to resolve the breakpoints may be to
conduct long-read single-molecule sequencing of the entire genome or
isolated sex chromosomes from an affected individual. In the absence of
such a resource we designed TaqMan copy number assays to genotype
Del-1 and Del-2 in cases, carriers, and controls as well as a population
sample. Our genotyping showed independent clustering of affected
individuals (Del-1/Del-1, Del-1/Del-2, and Del-2/Del-2), carriers (Del1/WT and Del-2/WT), and control individuals (WT/WT). Among the
genotyped individuals we only observed one Del-2/Del-2 individual
(Figure 5A), which was not surprising due to the low allele frequency
of Del-2 observed in the random set.
We did not observe any obvious phenotypic difference between Del1/Del-1 and Del-1/Del-2 individuals. More detailed bone and cartilage
phenotyping may make it possible to characterize whether there is a
difference between Del-1/Del-1 and Del-1/Del-2 individuals. Since all
individuals carrying two deletion alleles manifest an identical or at least
very similar disorder but only Del-1 removes the SHOX coding sequence, we expect the Del-2 deleted region to contain regulatory elements governing SHOX expression during development. However,
alignment of the Del-2 region on the human genome did not overlap
any annotated regulatory elements. Such regulatory elements may however still be unannotated in humans, may be unique to horse, or may be
missing from the SMRT assembly since some BACs were assembled
into contigs covering less than 50% of the estimated size of the BAC
clones. Thus, to characterize the presence of such elements more precisely, one would have to improve the assembly further and conduct
functional genomics screens.
Historically in Shetland pony breeding, small size combined with
strength and hardiness have been important traits under selection. Using
a small sample set of carriers we did not observe any signiﬁcant
association of this locus with height, but being restricted to a small
sample set of carriers we cannot exclude the possibility that the lack of
association was due to poor power to detect a true effect on height. It is
also possible that certain phenotypes associated with SA cases, for
example differences in phenotypic expression between Del-1 homozygotes and Del-1/Del-2 hemizygotes, or deletion carriers might have
been overlooked. Our ﬁndings can now be directly applied in breeding
programs to avoid foals born with skeletal atavism.
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